{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:48:58Z","timestamp":1783406938985,"version":"3.54.6"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alopecia, also known as hair loss, is a highly prevalent condition affecting millions of men and women in the United States and worldwide, making it one of the most common complaints by patients presenting to a dermatologist. The symptomology on the presentation of alopecia can be highly variable, ranging from diffuse thinning of hair, discrete and localized patches completely absent of hair, or noticing significant shedding when brushing and showering. Although alopecia does not have a direct negative health impact on patients, it is nonetheless a debilitating disease as it can profoundly impact an individual\u2019s self-image and psychosocial well-being. There are multiple treatment options available to patients with alopecia, and they are typically tailored to the patient\u2019s needs and preferences. The most common of these is the Food and Drug Administration-approved drugs for alopecia, minoxidil, and finasteride. However, both of these are known to be partially efficacious for all patients, so clinicians often use different modalities in conjunction with them, in particular laser-based therapies. This review article will provide a comprehensive assessment of lasers and other light therapies that may be used to manage the two most common types of alopecia: androgenetic alopecia and alopecia areata.<\/jats:p>","DOI":"10.1007\/s10103-024-04054-7","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:02:20Z","timestamp":1713326540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lasers in the management of alopecia: a review of established therapies and advances in treatment"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4447-6241","authenticated-orcid":false,"given":"Philippe","family":"Jean-Pierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Pulumati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Kasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"1","key":"4054_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli F, Pallotti F, Rossi A et al (2017) Androgenetic alopecia: a review. Endocrine 57(1):9\u201317. https:\/\/doi.org\/10.1007\/s12020-017-1280-y","journal-title":"Endocrine"},{"issue":"3","key":"4054_CR2","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1067\/mjd.2001.117428","volume":"45","author":"DA Whiting","year":"2001","unstructured":"Whiting DA (2001) Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 45(3):S81\u2013S86. https:\/\/doi.org\/10.1067\/mjd.2001.117428","journal-title":"J Am Acad Dermatol"},{"issue":"22","key":"4054_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399402005112","volume":"4","author":"JA Ellis","year":"2002","unstructured":"Ellis JA, Sinclair R, Harrap SB (2002) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4(22):1\u201311. https:\/\/doi.org\/10.1017\/S1462399402005112","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"4054_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/431425","volume":"77","author":"AM Hillmer","year":"2005","unstructured":"Hillmer AM, Hanneken S, Ritzmann S et al (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77(1):140\u2013148. https:\/\/doi.org\/10.1086\/431425","journal-title":"Am J Hum Genet"},{"issue":"6","key":"4054_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/jid.2013.43","volume":"133","author":"S Heilmann","year":"2013","unstructured":"Heilmann S, Kiefer AK, Fricker N et al (2013) Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology. J Invest Dermatology 133(6):1489\u20131496. https:\/\/doi.org\/10.1038\/jid.2013.43","journal-title":"J Invest Dermatology"},{"issue":"1","key":"4054_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jdv.14624","volume":"32","author":"V Kanti","year":"2017","unstructured":"Kanti V, Messenger A, Dobos G et al (2017) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol 32(1):11\u201322. https:\/\/doi.org\/10.1111\/jdv.14624","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4054_CR7","doi-asserted-by":"publisher","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL (2021) Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol 20(12). https:\/\/doi.org\/10.1111\/jocd.14537","DOI":"10.1111\/jocd.14537"},{"issue":"7","key":"4054_CR8","first-page":"56","volume":"9","author":"JM Hirshburg","year":"2016","unstructured":"Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS (2016) Adverse effects and safety of 5-alpha reductase inhibitors (Finasteride, Dutasteride): a systematic review. J Clin Aesthetic Dermatol 9(7):56\u201362. https:\/\/pubmed.ncbi.nlm.nih.gov\/27672412\/","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"04","key":"4054_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1055\/s-0041-1739255","volume":"54","author":"AK Garg","year":"2021","unstructured":"Garg AK, Garg S (2021) Complications of hair transplant procedures\u2014causes and management. Indian J Plast Surg 54(04):477\u2013482. https:\/\/doi.org\/10.1055\/s-0041-1739255","journal-title":"Indian J Plast Surg"},{"issue":"2","key":"4054_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.fsc.2020.01.003","volume":"28","author":"S Nadimi","year":"2020","unstructured":"Nadimi S (2020) Complications with hair transplantation. Facial Plast Surg Clin North Am 28(2):225\u2013235. https:\/\/doi.org\/10.1016\/j.fsc.2020.01.003","journal-title":"Facial Plast Surg Clin North Am"},{"key":"4054_CR11","doi-asserted-by":"publisher","unstructured":"Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP (2017) Alopecia areata. Nat Reviews Disease Primers 3(1). https:\/\/doi.org\/10.1038\/nrdp.2017.11","DOI":"10.1038\/nrdp.2017.11"},{"issue":"9","key":"4054_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/exd.12209","volume":"22","author":"KJ McElwee","year":"2013","unstructured":"McElwee KJ, Gilhar A, Tobin DJ et al (2013) What causes alopecia areata? Exp Dermatol 22(9):609\u2013626. https:\/\/doi.org\/10.1111\/exd.12209","journal-title":"Exp Dermatol"},{"key":"4054_CR13","doi-asserted-by":"publisher","unstructured":"Fukumoto T, Fukumoto R, Magno E, Oka M, Nishigori C, Horita N (2021) Treatments for alopecia areata: a systematic review and network meta-analysis. Dermatol Ther 34(3). https:\/\/doi.org\/10.1111\/dth.14916","DOI":"10.1111\/dth.14916"},{"issue":"1","key":"4054_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","volume":"28","author":"S Garg","year":"2009","unstructured":"Garg S, Messenger AG (2009) Alopecia areata: evidence-based treatments. Semin Cutan Med Surg 28(1):15\u201318. https:\/\/doi.org\/10.1016\/j.sder.2008.12.002","journal-title":"Semin Cutan Med Surg"},{"issue":"6","key":"4054_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40257-023-00808-1","volume":"24","author":"D Dahabreh","year":"2023","unstructured":"Dahabreh D, Jung S, Renert-Yuval Y, Bar J, Ester D, Duca Guttman\u2010YasskyE (2023) Alopecia areata: current treatments and new directions. Am J Clin Dermatol 24(6):895\u2013912. https:\/\/doi.org\/10.1007\/s40257-023-00808-1","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"4054_CR16","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/jcm9061724","volume":"9","author":"C Dompe","year":"2020","unstructured":"Dompe C, Moncrieff L, Matys J et al (2020) Photobiomodulation\u2014underlying mechanism and clinical applications. J Clin Med 9(6):1724. https:\/\/doi.org\/10.3390\/jcm9061724","journal-title":"J Clin Med"},{"issue":"5","key":"4054_CR17","first-page":"621","volume":"9","author":"E Mester","year":"1968","unstructured":"Mester E, Szende B, G\u00e4rtner P (1968) The effect of laser beams on the growth of hair in mice. Radiobiol Radiother 9(5):621\u2013626. https:\/\/pubmed.ncbi.nlm.nih.gov\/5732466\/","journal-title":"Radiobiol Radiother"},{"issue":"11","key":"4054_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1046\/j.1524-4725.2002.02101.x","volume":"28","author":"GA Moreno-Arias","year":"2002","unstructured":"Moreno-Arias GA, Camil Castelo-Branco FJ (2002) Paradoxical effect after IPL photoepilation. Dermatol Surg 28(11):1013\u20131016. https:\/\/doi.org\/10.1046\/j.1524-4725.2002.02101.x","journal-title":"Dermatol Surg"},{"issue":"1","key":"4054_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/lsm.22316","volume":"47","author":"YS Sheen","year":"2014","unstructured":"Sheen YS, Sabrina Mai-Yi F, Chan CC, Wu YF, Jee SH, Lin SJ (2014) Visible red light enhances physiological anagen entry in vivo and has direct and indirect stimulative effects in vitro. Lasers Surg Med 47(1):50\u201359. https:\/\/doi.org\/10.1002\/lsm.22316","journal-title":"Lasers Surg Med"},{"issue":"1","key":"4054_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14764170600607368","volume":"8","author":"M Waiz","year":"2006","unstructured":"Waiz M, Saleh AZ, Hayani R, Jubory SO (2006) Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata. J Cosmet Laser Therapy 8(1):27\u201330. https:\/\/doi.org\/10.1080\/14764170600607368","journal-title":"J Cosmet Laser Therapy"},{"issue":"5","key":"4054_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/00044011-200929050-00001","volume":"29","author":"M Leavitt","year":"2009","unstructured":"Leavitt M, Charles G, Heyman E, Michaels D (2009) HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig 29(5):283\u2013292. https:\/\/doi.org\/10.2165\/00044011-200929050-00001","journal-title":"Clin Drug Investig"},{"issue":"2","key":"4054_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","volume":"15","author":"JJ Jimenez","year":"2014","unstructured":"Jimenez JJ, Wikramanayake TC, Bergfeld W et al (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 15(2):115\u2013127. https:\/\/doi.org\/10.1007\/s40257-013-0060-6","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"4054_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/dsu.12200","volume":"39","author":"H Kim","year":"2013","unstructured":"Kim H, Choi JW, Kim JY, Shin JW, Lee S, Huh CH (2013) Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device\u2013controlled multicenter trial. Dermatol Surg 39(8):1177\u20131183. https:\/\/doi.org\/10.1111\/dsu.12200","journal-title":"Dermatol Surg"},{"issue":"9","key":"4054_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/lsm.22684","volume":"49","author":"SM Esmat","year":"2017","unstructured":"Esmat SM, Hegazy RA, Gawdat HI et al (2017) Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study. Lasers Surg Med 49(9):835\u2013843. https:\/\/doi.org\/10.1002\/lsm.22684","journal-title":"Lasers Surg Med"},{"key":"4054_CR25","doi-asserted-by":"publisher","unstructured":"Yu Y, Lu J, Zhang Y, Shi Y (2023) A prospective randomized half-body study: 308 nm LED light vs. 308 nm excimer laser for localized psoriasis. Front Med 10. https:\/\/doi.org\/10.3389\/fmed.2023.1275912","DOI":"10.3389\/fmed.2023.1275912"},{"key":"4054_CR26","doi-asserted-by":"publisher","unstructured":"Suo D, Zeng S, Meng L (2024) 308 nm excimer laser and tacrolimus ointment in the treatment of facial vitiligo: a systematic review and meta-analysis. Lasers Med Sci 39(1). https:\/\/doi.org\/10.1007\/s10103-024-04033-y","DOI":"10.1007\/s10103-024-04033-y"},{"key":"4054_CR27","doi-asserted-by":"publisher","unstructured":"Al-Mutairi N (2007) 308-nm excimer laser for the treatment of alopecia areata. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et. al] 33(12):1483\u20131487. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33320.x","DOI":"10.1111\/j.1524-4725.2007.33320.x"},{"issue":"3\u20134","key":"4054_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/1011-1344(90)85061-z","volume":"5","author":"JP Berthier","year":"1990","unstructured":"Berthier JP, Raynal E, Kimel S, Avrillier S, Ollivier JP (1990) XeCl laser action at medium fluences on biological tissues: fluorescence study and simulation with a chemical solution. J Photochem Photobiol B 5(3\u20134):495\u2013503. https:\/\/doi.org\/10.1016\/1011-1344(90)85061-z","journal-title":"J Photochem Photobiol B"},{"issue":"5","key":"4054_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","volume":"51","author":"W Zakaria","year":"2004","unstructured":"Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP (2004) 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol 51(5):837\u2013838. https:\/\/doi.org\/10.1016\/j.jaad.2004.05.026","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4054_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/phpp.12775","volume":"38","author":"Y DF","year":"2022","unstructured":"DF Y, Passeron HM (2022) Efficacy of 308-nm excimer therapy in alopecia areata: a retrospective study with long\u2010term follow\u2010up. PhotoDermatol PhotoImmunol PhotoMed 38(5):507\u2013510. https:\/\/doi.org\/10.1111\/phpp.12775","journal-title":"PhotoDermatol PhotoImmunol PhotoMed"},{"key":"4054_CR31","doi-asserted-by":"publisher","unstructured":"Kianfar N, Dasdar S, Mahmoudi H et al (2021) Comparison of the efficacy and safety of 308-nm excimer laser with intralesional corticosteroids for the treatment of alopecia areata: a randomized controlled study. Lasers in surgery and medicine. Published Online Dec 2. https:\/\/doi.org\/10.1002\/lsm.23501","DOI":"10.1002\/lsm.23501"},{"issue":"3","key":"4054_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J et al (2022) Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Therapy 7(3):3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Therapy"},{"key":"4054_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04230.x","author":"KH Yoo","year":"2009","unstructured":"Yoo KH, Kim MN, Kim BJ, Kim CW (2009) Treatment of alopecia areata with fractional photothermolysis laser. Int J Dermatology Published Online July. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04230.x","journal-title":"Int J Dermatology Published Online July"},{"issue":"4","key":"4054_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/lsm.22227","volume":"46","author":"LR Sklar","year":"2014","unstructured":"Sklar LR, Burnett CT, Waibel JS, Moy RL, Ozog DM (2014) Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med 46(4):249\u2013262. https:\/\/doi.org\/10.1002\/lsm.22227","journal-title":"Lasers Surg Med"},{"issue":"10","key":"4054_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/lsm.23133","volume":"51","author":"MA Al-Dhalimi","year":"2019","unstructured":"Al-Dhalimi MA, Al\u2010Janabi MH, Abd Al Hussein RA (2019) The use of a 1,540 nm fractional erbium\u2010glass laser in treatment of alopecia areata. Lasers Surg Med 51(10):859\u2013865. https:\/\/doi.org\/10.1002\/lsm.23133","journal-title":"Lasers Surg Med"},{"key":"4054_CR36","doi-asserted-by":"publisher","unstructured":"Eckert MM, Gundin NL, Crespo RL (2016) Alopecia areata: good response to treatment with fractional laser in 5 cases. J Cosmetology Trichology 2(2). https:\/\/doi.org\/10.4172\/2471-9323.1000108","DOI":"10.4172\/2471-9323.1000108"},{"issue":"1","key":"4054_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1524-4725.2010.01833.x","volume":"37","author":"WS KIM","year":"2011","unstructured":"KIM WS, LEE HI, LEE JW et al (2011) Fractional photothermolysis laser treatment of male pattern hair loss. Dermatol Surg 37(1):41\u201351. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01833.x","journal-title":"Dermatol Surg"},{"issue":"2","key":"4054_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/jcas.jcas_171_18","volume":"12","author":"S Arsiwala","year":"2019","unstructured":"Arsiwala S, Desai S (2019) Fractional carbon dioxide laser: optimizing treatment outcomes for pigmented atrophic acne scars in skin of color. J Cutan Aesthetic Surg 12(2):85. https:\/\/doi.org\/10.4103\/jcas.jcas_171_18","journal-title":"J Cutan Aesthetic Surg"},{"issue":"1","key":"4054_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5978\/islsm.14-RE-01","volume":"23","author":"T Omi","year":"2014","unstructured":"Omi T, Numano K (2014) The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Therapy 23(1):49\u201360. https:\/\/doi.org\/10.5978\/islsm.14-RE-01","journal-title":"Laser Therapy"},{"issue":"4","key":"4054_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/jcas.jcas_96_18","volume":"11","author":"I Majid","year":"2018","unstructured":"Majid I, Jeelani S, Imran S (2018) Fractional carbon dioxide laser in combination with topical corticosteroid application in resistant alopecia areata: a case series. J Cutan Aesthetic Surg 11(4):217. https:\/\/doi.org\/10.4103\/jcas.jcas_96_18","journal-title":"J Cutan Aesthetic Surg"},{"issue":"3","key":"4054_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00403-022-02393-5","volume":"315","author":"M Dalia Abdel Halim, Nayer","year":"2022","unstructured":"Dalia Abdel Halim, Nayer M, El-Samanoudy SI, Abdel M, Ragab N (2022) Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study. Arch Dermatol Res 315(3):505\u2013511. https:\/\/doi.org\/10.1007\/s00403-022-02393-5","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"4054_CR42","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s10103-017-2232-8","volume":"32","author":"Y Huang","year":"2017","unstructured":"Huang Y, Zhuo F, Li L (2017) Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors. Lasers Med Sci 32(8):1711\u20131718. https:\/\/doi.org\/10.1007\/s10103-017-2232-8","journal-title":"Lasers Med Sci"},{"key":"4054_CR43","unstructured":"Rathod DG, Muneer H, Masood S (2024) Phototherapy. PubMed. Published. Accessed 26 Mar 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563140\/"},{"key":"4054_CR44","unstructured":"Bulat (2014) The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol 35 Suppl 2. https:\/\/pubmed.ncbi.nlm.nih.gov\/22220423\/"},{"issue":"2","key":"4054_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","volume":"31","author":"CS Jury","year":"2006","unstructured":"Jury CS, McHenry P, Burden AD, Lever R, Bilsland D (2006) Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol 31(2):196\u2013199. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02061.x","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"4054_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-0781.2011.00612.x","volume":"27","author":"D Bayramg\u00fcrler","year":"2011","unstructured":"Bayramg\u00fcrler D, Demirsoy EO, Akt\u00fcrk A\u015e, K\u0131ran R (2011) Narrowband ultraviolet B phototherapy for alopecia areata. PhotoDermatol PhotoImmunol PhotoMed 27(6):325\u2013327. https:\/\/doi.org\/10.1111\/j.1600-0781.2011.00612.x","journal-title":"PhotoDermatol PhotoImmunol PhotoMed"},{"issue":"2","key":"4054_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3906\/sag-1810-110","volume":"49","author":"ESEN SALMAN K","year":"2019","unstructured":"ESEN SALMAN K (2019) The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study. Turk J Med Sci 49(2):595\u2013603. https:\/\/doi.org\/10.3906\/sag-1810-110","journal-title":"Turk J Med Sci"},{"issue":"8","key":"4054_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00403-019-01943-8","volume":"311","author":"MA El Taieb","year":"2019","unstructured":"El Taieb MA, Hegazy EM, Ibrahim HM, Osman AB, Abualhamd M (2019) Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial. Arch Dermatol Res 311(8):629\u2013636. https:\/\/doi.org\/10.1007\/s00403-019-01943-8","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"4054_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.det.2019.08.011","volume":"38","author":"S Prasad","year":"2020","unstructured":"Prasad S, Coias J, Chen HW, Jacobe H (2020) Utilizing UVA-1 phototherapy. Dermatol Clin 38(1):79\u201390. https:\/\/doi.org\/10.1016\/j.det.2019.08.011","journal-title":"Dermatol Clin"},{"issue":"6","key":"4054_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-4632.2009.04427.x","volume":"49","author":"NR York","year":"2010","unstructured":"York NR, Jacobe HT (2010) UVA1 phototherapy: a review of mechanism and therapeutic application. Int J Dermatol 49(6):623\u2013630. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04427.x","journal-title":"Int J Dermatol"},{"issue":"6","key":"4054_CR51","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/ijd.13572","volume":"56","author":"ME Herz-Ruelas","year":"2017","unstructured":"Herz-Ruelas ME, Gomez-Flores M, Ivett Miranda-Maldonado WE, Ocampo-Candiani J, Welsh O (2017) Escalating dosimetry of UVA-1 in the treatment of alopecia areata. Int J Dermatol 56(6):653\u2013659. https:\/\/doi.org\/10.1111\/ijd.13572","journal-title":"Int J Dermatol"},{"issue":"2","key":"4054_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5021\/ad.2012.24.2.162","volume":"24","author":"YJ Kim","year":"2012","unstructured":"Kim YJ, Whang KU, Choi WB et al (2012) Efficacy and safety of 1,064 nm Q-switched nd:YAG laser treatment for removing melanocytic nevi. Ann Dermatol 24(2):162. https:\/\/doi.org\/10.5021\/ad.2012.24.2.162","journal-title":"Ann Dermatol"},{"issue":"2","key":"4054_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/bjd.14962","volume":"176","author":"F Pinto","year":"2017","unstructured":"Pinto F, Gro\u00dfe-B\u00fcning S, Karsai S et al (2017) Neodymium-doped yttrium aluminium garnet (nd:YAG) 1064-nm picosecond laser vs. nd:YAG 1064-nm nanosecond laser in tattoo removal: a randomized controlled single-blind clinical trial. Br J Dermatol 176(2):457\u2013464. https:\/\/doi.org\/10.1111\/bjd.14962","journal-title":"Br J Dermatol"},{"issue":"7","key":"4054_CR54","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/app9071298","volume":"9","author":"SJ Juang","year":"2019","unstructured":"Juang SJ, Tsai TH, Wang SH, Chi CC (2019) Alopecia totalis treated with 1064 nm picosecond Nd:YAG laser: a case report. Appl Sci 9(7):1298\u20131298. https:\/\/doi.org\/10.3390\/app9071298","journal-title":"Appl Sci"},{"issue":"8","key":"4054_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/lsm.22065","volume":"44","author":"T Fujimoto","year":"2012","unstructured":"Fujimoto T, Ito S, Ito M, Kanazawa H, Yamaguchi S (2012) Induction of different reactive oxygen species in the skin during various laser therapies and their inhibition by fullerene. Lasers Surg Med 44(8):685\u2013694. https:\/\/doi.org\/10.1002\/lsm.22065","journal-title":"Lasers Surg Med"},{"key":"4054_CR56","doi-asserted-by":"publisher","unstructured":"Lavi R, Asher Shainberg V, Shneyvays et al (2010) Detailed analysis of reactive oxygen species induced by visible light in various cell types. 42(6):473\u2013480. https:\/\/doi.org\/10.1002\/lsm.20919","DOI":"10.1002\/lsm.20919"},{"issue":"12","key":"4054_CR57","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1038\/sj.jid.5700340","volume":"126","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Invest Dermatology 126(12):2565\u20132575. https:\/\/doi.org\/10.1038\/sj.jid.5700340","journal-title":"J Invest Dermatology"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-024-04054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-024-04054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:44:40Z","timestamp":1738338280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-024-04054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4054"],"URL":"https:\/\/doi.org\/10.1007\/s10103-024-04054-7","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"102"}}